Department of Cardiothoracic Surgery, Erasmus Medical Center, Room Bd 575, PO Box 2040, 3000 CA Rotterdam, the Netherlands.
Circulation. 2011 Jan 4;123(1):31-8. doi: 10.1161/CIRCULATIONAHA.110.947341. Epub 2010 Dec 20.
It is suggested that in young adults the Ross procedure results in better late patient survival compared with mechanical prosthesis implantation. We performed a propensity score-matched study that assessed late survival in young adult patients after a Ross procedure versus that after mechanical aortic valve replacement with optimal self-management anticoagulation therapy.
We selected 918 Ross patients and 406 mechanical valve patients 18 to 60 years of age without dissection, aneurysm, or mitral valve replacement who survived an elective procedure (1994 to 2008). With the use of propensity score matching, late survival was compared between the 2 groups. Two hundred fifty-three patients with a mechanical valve (mean follow-up, 6.3 years) could be propensity matched to a Ross patient (mean follow-up, 5.1 years). Mean age of the matched cohort was 47.3 years in the Ross procedure group and 48.0 years in the mechanical valve group (P=0.17); the ratio of male to female patients was 3.2 in the Ross procedure group and 2.7 in the mechanical valve group (P=0.46). Linearized all-cause mortality rate was 0.53% per patient-year in the Ross procedure group compared with 0.30% per patient-year in the mechanical valve group (matched hazard ratio, 1.86; 95% confidence interval, 0.58 to 5.91; P=0.32). Late survival was comparable to that of the general German population.
In comparable patients, there is no late survival difference in the first postoperative decade between the Ross procedure and mechanical aortic valve implantation with optimal anticoagulation self-management. Survival in these selected young adult patients closely resembles that of the general population, possibly as a result of highly specialized anticoagulation self-management, better timing of surgery, and improved patient selection in recent years.
有研究表明,在年轻患者中,与机械瓣膜置换相比,Ross 手术可获得更好的晚期患者生存率。我们进行了一项倾向评分匹配研究,评估了在接受 Ross 手术与接受机械主动脉瓣置换(同时接受最佳自我管理抗凝治疗)的年轻患者的晚期生存情况。
我们选择了 1994 年至 2008 年期间行择期手术且无夹层、动脉瘤或二尖瓣置换的 18 至 60 岁的 918 例 Ross 患者和 406 例机械瓣膜患者。采用倾向评分匹配比较两组的晚期生存情况。253 例机械瓣膜患者(平均随访时间 6.3 年)可与 Ross 患者进行倾向评分匹配(平均随访时间 5.1 年)。Ross 手术组匹配队列的平均年龄为 47.3 岁,机械瓣膜组为 48.0 岁(P=0.17);Ross 手术组男女患者比例为 3.2,机械瓣膜组为 2.7(P=0.46)。Ross 手术组的线性化全因死亡率为 0.53%/患者年,机械瓣膜组为 0.30%/患者年(匹配危险比为 1.86;95%置信区间为 0.58 至 5.91;P=0.32)。晚期生存情况与德国一般人群相当。
在可比较的患者中,在接受最佳抗凝自我管理的情况下,Ross 手术与机械主动脉瓣置换在术后第一个十年的晚期生存无差异。这些选择的年轻患者的生存情况与一般人群非常相似,这可能是由于高度专业化的抗凝自我管理、手术时机的改善以及近年来患者选择的改善。